Abstract
This is a descriptive cross-sectional study. The aim of this study is to find the cost-effectiveness of giving AZT to prevent the transmission of HIV from mother to child and to compare the result of this study to previous studies in the aspect of provider and consumer perspective. The information summarized from this study would be a policy implication for Bangkok Metropolitan Office for properly administration of AZT to HIV-infected pregnant women to prevent the transmission of HIV. Overall, 80 percent of mother received AZT before delivery. Normal delivery was accounted for 63.5% and 130 mothers (24.6%) were appointed for cesarean section and/or having cesarean section. In mother with normal delivery, average cost on procedures, medicines and medical consumables was 2,900 TBH, average cost on labor cost and all cost was 3,250 and 6,150 TBH respectively. In mother with cesarean section, average cost on procedures, medicines and medical consumables was 6,000-11,050 TBH, average cost on labor and all cost was 3,550-4,500 and 9,550-14,400 TBH respectively. Overall, 7 of 103 (6.8%) children were HIV positive. The administration of AZT in overall was not related to cost on procedures, medicines and medical consumables but was accounted for the increasing of labor and all cost by 420 TBH. The difference of having AZT once and twice before delivery was accounted for the increasing of all cost by 1,900 TBH, whilst there was no difference of all cost between giving AZT for one time and no AZT. So, it is suggested that the budget of giving AZT is not only for the cost of drug but also for the administration of drug such as PCR testing.
